Home > About Us
Who We Are
Compass Bioinformatics is committed to becoming a global leader in Software as a Medical Device (SaMD) for multi-omics. We are a team of clinicians, AI data scientists, bioinformatics experts, and system developers across USA, Japan, and Taiwan.
On the path to conquering rare disorder diagnoses.
Since the first case in 2019 when the Compass solution was used to uncover a child’s condition - Alstrom Syndrome - we have helped over 3500 other patients in the last of 5 years.
There are 300 million patients with rare disorders across the world and each year 7 million new patients are affected.
Each instance of identifying the one true variant in three billion consumes the time, expertise, and care of overly taxed medical experts, which can lead to delays and misdiagnoses
Mission
The mission of Compass Bioinformatics is to usher in the era of personal genomics by making genomics analyses accessible, efficient, and inexpensive with the most sophisticated artificial intelligence algorithms.
At Compass Bioinformatics Inc., we are pioneering comprehensive human genome sequencing to learn more about the underlying causes of disease and laying the framework for AI-driven genetic analysis for all future generations.
We can create a healthier, more informed world for all of us with the help of InheriNext® user-friendly, efficient software.
Our Team
Leadership Team
Our team consists of medical & technological professionals & top-tier industry experts. Together, we bring decades of experience, innovation, and strategies to guide our mission. Our diverse backgrounds ensure we remain at the forefront of precision medicine, driving innovation and delivering high-quality solutions.
Scientific Advisory Board
Compass Bioinformatics drives innovation with expert insights from our advisors, ensuring alignment with industry best practices, emerging trends, and regulatory standards.
Compass In Action
Mar 18-22, 2025
We can't wait to connect with the global genetics community and showcase InheriNext®! Visit us at Booth 333 in the Startup Pavilion to see how we’re accelerating genomic insights with precision & innovation!🎉
Feb 5-7, 2025
At PMWC - Precision Medicine World Conference, our scientific advisor Scott Kahn unveiled #InheriNext®, our powerful interpretation & reporting platform designed to streamline the identification of relevant genetic variants. Our 1st benchmark study on 7244 simulated samples using #phenopacket data captured the correct variant with 98.63% recall rate! ...
